Progress in cystic fibrosis and the CF Therapeutics Development Network

Cystic fibrosis (CF), the most common life-shortening genetic disorder in Caucasians, affects approximately 70 000 individuals worldwide. In 1998, the Cystic Fibrosis Foundation (CFF) launched the CF Therapeutics Development Network (CF-TDN) as a central element of its Therapeutics Development Progr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rowe, Steven M, Borowitz, Drucy S, Burns, Jane L, Clancy, John P, Donaldson, Scott H, Retsch-Bogart, George, Sagel, Scott D, Ramsey, Bonnie W
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787701/
https://ncbi.nlm.nih.gov/pubmed/22960984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2012-202550
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires